Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Lutetium-177"”.

  1. Fabrication of a novel radiopharmaceutical: lutetium-177 loaded MCM-41mesoporous silica

    … been explored. A method for loading [superscript 177]Lu into MCM-41 was evaluated by varying starting material and loading reaction factors. For the procedure of [superscript 177]Lu loaded MCM-41, cetyltrimethylammonium bromide was dissolved in a solution of 384 ml of MilliQ water heated at …

    missouri Repository record for Fabrication of a novel radiopharmaceutical: lutetium-177 loaded MCM-41mesoporous silica (opens in a new tab)

  2. Competition in the radioisotopes market: evaluation and analysis of drivers which affect mo-99 market share

    … are not limited to Mo-99, Iodine-131 (I-131), Lutetium 177 non-carrier-added (Lu-177 n.c.a.) & Fluorine-18 (F-18)), that are used as Active Pharmaceutical Ingredients (APIs) for the manufacture of radiopharmaceuticals. The most prevalent diagnostic radioisotope among these fission isotopes, …

    western-cape Repository record for Competition in the radioisotopes market: evaluation and analysis of drivers which affect mo-99 market share (opens in a new tab)

  3. Radioimmunotherapy of Metastatic Disease - Studies of Alpha- and Beta-particle-Emitting Radionuclides in a Preclinical Model

    … with different properties were used. Lutetium-177 (177Lu) is a beta-particle-emitting radionuclide (t½=6.7 days) and astatine-211 (211At) emits alpha particles (t½=7.2 h). These radionuclides were used to label a mAb targeting the Lewis Y antigen expressed on many carcinomas. A …

    lund Repository record for Radioimmunotherapy of Metastatic Disease - Studies of Alpha- and Beta-particle-Emitting Radionuclides in a Preclinical Model (opens in a new tab)